User: I want to know more about the compound with SMILES C#Cc1cnc2nc(O)n(C(CC)CC)c2n1.
Assistant: How can I help?
User: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Assistant: The answer is Phase 3 Clinical Trials
User: I want to know more about the {#molecule|chemical|compound!} with {SMILES__description} {SMILES#}.
Assistant: {#Sure, what is your question?|How can I help?|That sounds interesting, how can I help?|Interesting, how can I help?!}
User: {quest#}
Assistant: {#The answer is |!}{answ#}
C#Cc1cnc2nc(O)n(C(CC)CC)c2n1
C#Cc1cnc2nc(O)n(C(CC)CC)c2n1
5-ethynyl-3-pentan-3-ylimidazo[4,5-b]pyrazin-2-ol
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.